Literature DB >> 22969192

Results of National Colorectal Cancer Screening Program in Croatia (2007-2011).

Miroslava Katičić1, Nataša Antoljak, Milan Kujundžić, Valerija Stamenić, Dunja Skoko Poljak, Danica Kramarić, Davor Stimac, Marija Strnad Pešikan, Mirko Samija, Zdravko Ebling.   

Abstract

AIM: To study the epidemiologic indicators of uptake and characteristic colonoscopic findings in the Croatian National Colorectal Cancer Screening Program.
METHODS: Colorectal cancer (CRC) was the second leading cause of cancer mortality in men (n = 1063, 49.77/100,000), as well as women (n = 803, 34.89/100,000) in Croatia in 2009. The Croatian National CRC Screening Program was established by the Ministry of Health and Social Welfare, and its implementation started in September, 2007. The coordinators were recruited in each county institute of public health with an obligation to provide fecal occult blood testing (FOBT) to the participants, followed by colonoscopy in all positive cases. The FOBT was performed by hypersensitive guaiac-based Hemognost card test (Biognost, Zagreb). The test and short questionnaire were delivered to the home addresses of all citizens aged 50-74 years consecutively during a 3-year period. Each participant was required to complete the questionnaire and send it together with the stool specimen on three test cards back to the institute for further analysis. About 4% FOBT positive cases are expected in normal risk populations. A descriptive analysis was performed.
RESULTS: A total of 1,056,694 individuals (born between 1933-1945 and 1952-1957) were invited to screening by the end of September 2011. In total, 210,239 (19.9%) persons returned the envelope with a completed questionnaire, and 181,102 of them returned it with a correctly placed stool specimen on FOBT cards. Until now, 12,477 (6.9%), FOBT-positive patients have been found, which is at the upper limit of the expected values in European Guidelines for Quality Assurance in CRC Screening and Diagnosis [European Union (EU) Guidelines]. Colonoscopy was performed in 8541 cases (uptake 66%). Screening has identified CRC in 472 patients (5.5% of colonoscopied, 3.8% of FOBT-positive, and 0.26% of all screened individuals). This is also in the expected range according to EU Guidelines. Polyps were found and removed in 3329 (39% of colonoscopied) patients. The largest number of polyps were found in the left half of the colon: 64% (19%, 37% and 8% in the rectum, sigma, and descendens, respectively). The other 36% were detected in the proximal part (17% in the transverse colon and 19% in ceco-ascending colon). Small polyps in the rectum (5-10 mm in diameter), sigmoid and descending colon were histologically found to be tubular adenomas in 60% of cases, with a low degree of dysplasia, and 40% were classified as hyperplastic. Polyps of this size in the transverse or ceco-ascending colon in almost 20% had a histologically villous component, but still had a low degree of dysplasia. Polyps sized 10-20 mm in diameter were in 43% cases tubulovillous, and among them, 32% had areas with a high degree of dysplasia, especially those polyps in the ceco-ascending or transverse part. The characteristics of the Croatian CRC Screening National Program in the first 3 years were as follows: relatively low percentage of returned FOBT, higher number of FOBT-positive persons but still in the range for population-based programs, and higher number of pathologic findings (polyps and cancers).
CONCLUSION: These results suggest a need for intervention strategies that include organizational changes and educational activities to improve awareness of CRC screening usefulness and increase participation rates.

Entities:  

Keywords:  Colonoscopy; Colorectal cancer screening; Croatian National Colorectal Cancer Screening Program; Fecal occult blood testing; Uptake

Mesh:

Year:  2012        PMID: 22969192      PMCID: PMC3436044          DOI: 10.3748/wjg.v18.i32.4300

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  34 in total

1.  The effect of fecal occult-blood screening on the incidence of colorectal cancer.

Authors:  J S Mandel; T R Church; J H Bond; F Ederer; M S Geisser; S J Mongin; D C Snover; L M Schuman
Journal:  N Engl J Med       Date:  2000-11-30       Impact factor: 91.245

2.  Direct mailing of faecal occult blood tests for colorectal cancer screening: a randomized population study from Central Italy.

Authors:  Paolo Giorgi Rossi; Grazia Grazzini; Marcello Anti; Diego Baiocchi; Alessandra Barca; Paola Bellardini; Silvia Brezzi; Laura Camilloni; Patrizia Falini; Vincenzo Maccallini; Paola Mantellini; Daniele Romeo; Tiziana Rubeca; Maria Antonietta Venditti
Journal:  J Med Screen       Date:  2011       Impact factor: 2.136

Review 3.  Isolated colorectal cancer screening or integrated cancer prevention? A provocative suggestion!

Authors:  Reinhold Stockbrugger
Journal:  Dig Dis       Date:  2012-06-20       Impact factor: 2.404

4.  Improving the fecal occult-blood test.

Authors:  J E Allison; I S Tekawa; L J Ransom; A L Adrain
Journal:  N Engl J Med       Date:  1996-06-13       Impact factor: 91.245

5.  Cancer statistics, 2010.

Authors:  Ahmedin Jemal; Rebecca Siegel; Jiaquan Xu; Elizabeth Ward
Journal:  CA Cancer J Clin       Date:  2010-07-07       Impact factor: 508.702

6.  Perspectives of colorectal cancer screening in Germany 2009.

Authors:  Andreas Sieg; Kilian Friedrich
Journal:  World J Gastrointest Endosc       Date:  2009-10-15

Review 7.  Use of faecal markers in screening for colorectal neoplasia: a European group on tumor markers position paper.

Authors:  Michael J Duffy; Leo G M van Rossum; Sietze T van Turenhout; Outi Malminiemi; Catherine Sturgeon; Rolf Lamerz; Andrea Nicolini; Caj Haglund; Lubos Holubec; Callum G Fraser; Stephen P Halloran
Journal:  Int J Cancer       Date:  2011-01-01       Impact factor: 7.396

8.  False-positive results from colorectal cancer screening in Catalonia (Spain), 2000-2010.

Authors:  Montse Garcia; Núria Milà; Gemma Binefa; Josep Maria Borràs; Josep Alfons Espinàs; Víctor Moreno
Journal:  J Med Screen       Date:  2012-05-31       Impact factor: 2.136

9.  Population-based screening for colorectal cancer using an immunochemical faecal occult blood test: a comparison of two invitation strategies.

Authors:  Sofie Van Roosbroeck; Sarah Hoeck; Guido Van Hal
Journal:  Cancer Epidemiol       Date:  2012-05-05       Impact factor: 2.984

10.  Incidence and mortality trends of gastric and colorectal cancers in Croatia, 1988-2008.

Authors:  Iva Kirac; Mario Sekerija; Iva Simunović; Lina Zgaga; Danko Velimir Vrdoljak; Dujo Kovacević; Tomislav Kulis; Ariana Znaor
Journal:  Croat Med J       Date:  2012-04       Impact factor: 1.351

View more
  13 in total

1.  Comparison of biomarker expression between proximal and distal colorectal adenomas: The Tennessee-Indiana Adenoma Recurrence Study.

Authors:  Timothy Su; M Kay Washington; Reid M Ness; Douglas K Rex; Walter E Smalley; Thomas M Ulbright; Qiuyin Cai; Wei Zheng; Martha J Shrubsole
Journal:  Mol Carcinog       Date:  2016-08-11       Impact factor: 4.784

2.  The First Screening Program for Colorectal Cancer in the North of Iran.

Authors:  Hossein-Ali Nikbakht; Javad Shokri-Shirvani; Hassan Ashrafian-Amiri; Haleh Ghaem; Ali Jafarnia; Sedigheh Alijanpour; Seyed-Mostaffa Mirzad; Soheil Hassanipour
Journal:  J Gastrointest Cancer       Date:  2020-03

3.  Endoscopic features and clinical course of patients with asymptomatic cecal ulcers.

Authors:  Fang-We Chiu; Chung-Wang Ko; Ying-Cheng Lin; Szu-Chia Liao; Chung-Hsin Chang; Chia-Chang Chen; Wan-Tzu Lin
Journal:  BMC Gastroenterol       Date:  2022-06-24       Impact factor: 2.847

4.  Fecal Occult Blood Test Results of the National Colorectal Cancer Screening Program in South Korea (2006-2013).

Authors:  John Hoon Rim; Taemi Youk; Jung Gu Kang; Byung Kyu Park; Heon Yung Gee; Jeong-Ho Kim; Jongha Yoo
Journal:  Sci Rep       Date:  2017-06-05       Impact factor: 4.379

Review 5.  Colorectal cancer population screening programs worldwide in 2016: An update.

Authors:  Mercedes Navarro; Andrea Nicolas; Angel Ferrandez; Angel Lanas
Journal:  World J Gastroenterol       Date:  2017-05-28       Impact factor: 5.742

6.  SMAD7 variant rs4939827 is associated with colorectal cancer risk in Croatian population.

Authors:  Iva Kirac; Petar Matošević; Goran Augustin; Iva Šimunović; Vedran Hostić; Sven Župančić; Caroline Hayward; Natasa Antoljak; Igor Rudan; Harry Campbell; Malcolm G Dunlop; Danko Velimir Vrdoljak; Dujo Kovačević; Lina Zgaga
Journal:  PLoS One       Date:  2013-09-16       Impact factor: 3.240

7.  Organised colorectal cancer screening in Lampang Province, Thailand: preliminary results from a pilot implementation programme.

Authors:  Thiravud Khuhaprema; Suleeporn Sangrajrang; Somkiat Lalitwongsa; Vanida Chokvanitphong; Tawarat Raunroadroong; Tawee Ratanachu-Ek; Richard Muwonge; Eric Lucas; Christopher Wild; Rengaswamy Sankaranarayanan
Journal:  BMJ Open       Date:  2014-01-15       Impact factor: 2.692

8.  Amblyopia screening: a new screening protocol implemented in Croatia.

Authors:  Mladen Bušić; Mirjana Bjeloš; Biljana Kuzmanović Elabjer
Journal:  Croat Med J       Date:  2016-02       Impact factor: 1.351

Review 9.  Colorectal Cancer Screening-Who, How, and When?

Authors:  Roisin Bevan; Matthew D Rutter
Journal:  Clin Endosc       Date:  2018-01-31

Review 10.  Microbial markers in colorectal cancer detection and/or prognosis.

Authors:  Romain Villéger; Amélie Lopès; Julie Veziant; Johan Gagnière; Nicolas Barnich; Elisabeth Billard; Delphine Boucher; Mathilde Bonnet
Journal:  World J Gastroenterol       Date:  2018-06-14       Impact factor: 5.374

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.